Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022. - Yang H; Meng X; Zhuang T; Wang C; Yang Z; Zhu T; Li M; Zheng Y; Wu Q; Hu Y; Yu H; Liu X; et al. (China CDC weekly, 2023)